{"nct_id":"NCT00989404","title":"Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days","status":"COMPLETED","status_verified_date":"2017-06","start_date":"2009-10-12","start_date_type":"ACTUAL","primary_completion_date":"2009-12-07","primary_completion_date_type":"ACTUAL","completion_date":"2009-12-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}